Extensions

Patent Term Adjustments (PTA) for US Patent 12096974

Patent Term Adjustment (PTA) is granted by the USPTO to compensate applicants for certain delays that occur during the prosecution of a patent application. These delays can include:

• Failure by the USPTO to issue a first Office Action or notice of allowance within 14 months of the application's filing date.
• Failure by the USPTO to act within four months of an applicant's reply to an Office Action.
• Failure by the USPTO to issue a patent within four months of payment of the issue fee.
• Failure by the USPTO to issue a patent within three years of the actual filing date of the application.

For US Patent 12096974, the filing date was April 26, 2024, and the publication date was September 24, 2024. The granted patent indicates the application was issued well within the 3-year period from filing to issuance. Without access to the specific prosecution history of application US18/647,929, it is not possible to definitively calculate any PTA. However, given the relatively short time between filing and grant (April 26, 2024 to September 24, 2024), it is unlikely that significant USPTO delays triggering substantial PTA would have occurred. The notice of allowance, which typically includes the PTA calculation, would provide the precise adjustment.

Patent Term Extensions (PTE) for US Patent 12096974

Patent Term Extension (PTE) is available for patents claiming products, methods of use, or methods of manufacturing products that require pre-market regulatory review by agencies like the FDA or USDA, such as drug products, medical devices, food additives, or color additives. The maximum length of a PTE is five years.

US Patent 12096974, titled "Systems and methods for therapeutic nasal treatment using handheld device," relates to a medical device for therapeutic treatment. This type of invention (medical device) is potentially eligible for a PTE if it undergoes regulatory review by the FDA.

To determine if a PTE has been granted for US Patent 12096974, an application for extension must be submitted to the USPTO within 60 days of the regulatory agency's approval of the commercial marketing application for the product. The USPTO publishes a list of patent terms extended. Without information about FDA approval for a specific product covered by this patent, it is not possible to confirm if a PTE has been applied for or granted.

Continuation and Divisional Applications for US Patent 12096974

A continuation application is a new application derived from an earlier, still-pending application, pursuing additional claims to an invention already disclosed in the earlier application, and claiming priority to it. A divisional application is also a type of continuing application, filed when an earlier application claimed more than one invention.

According to the provided patent information, US Patent 12096974 resulted from application number US18/647,929. The information does not explicitly list any continuation or divisional applications directly stemming from US12096974 or its parent application.

Related Family Members for US Patent 12096974

The provided information lists US20240293175A1 as another version or family member of US Patent 12096974. This is a patent application publication corresponding to the granted patent.

Projected Expiration Date for US Patent 12096974

The general term for a US patent is 20 years from its earliest filing date. US Patent 12096974 has a priority date and a filing date of April 9, 2020, and April 26, 2024, respectively, for application US18/647,929. The patent states a "Prior art date" of 2020-04-09, and a "Priority date" of 2020-04-09. Assuming the earliest priority date of April 9, 2020, is the effective filing date for term calculation purposes, the basic expiration date would be April 9, 2040. However, the patent's metadata specifically lists "Anticipated expiration" as 2041-04-08.

This difference of approximately one year between the 20-year term from the earliest priority date and the anticipated expiration date suggests that there has been a Patent Term Adjustment (PTA) of approximately one year. Without the official PTA calculation from the USPTO, the exact reason for this adjustment cannot be determined, but it would compensate for delays in prosecution.

Therefore, the projected expiration date for US Patent 12096974, based on the provided patent information, is April 8, 2041.